RT Journal Article
SR Electronic
T1 682 Trial in progress: phase 1 trial of TSC-100 and TSC-101, engineered T-cell therapies targeting minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantation
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A774
OP A774
DO 10.1136/jitc-2023-SITC2023.0682
VO 11
IS Suppl 1
A1 Malki, Monzr Al
A1 Keyzner, Alla
A1 Suh, Hyung C
A1 Matin, Aasiya
A1 Buonomo, Erica
A1 Wang, Yun
A1 Abelowitz, Nina
A1 Murray, Jim
A1 MacBeath, Gavin
A1 Barton, Debora
A1 Chattopadhyay, Shrikanta
A1 Reshef, Ran
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A774.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.